GatePass Capital’s Biote Corp BTMD Stock Holding History

GatePass Capital’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$201K	–	146
2025 Q2	$201K	Buy	50,000 +38,000	+317%	+$140K	0.13%	115
2025 Q1	$40K	Buy	+12,000	New	+$57.2K	0.03%	114

Other funds holding BTMD

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

GatePass Capital's BTMD Position: Q3 2025 in Review

GatePass Capital sold out of Biote Corp (BTMD) in Q3 2025, closing a stake of 50,000 shares — an estimated $201K sold.

GatePass Capital first reported a position in BTMD in Q1 2025 and held it in 2 quarters. The position peaked at $201K in Q2 2025. 87 funds tracked by Wall St. Rank hold BTMD as of Q3 2025.

GatePass Capital reported no remaining Biote Corp position as of Q3 2025 after selling out during the quarter.
GatePass Capital sold 50,000 Biote Corp shares in Q3 2025, an estimated $201K.
GatePass Capital first reported a position in Biote Corp in Q1 2025 and held it in 2 quarters.
GatePass Capital's Biote Corp position peaked at $201K in Q2 2025.
87 funds tracked by Wall St. Rank held Biote Corp as of Q3 2025.

Based on GatePass Capital's 13F filing for Q3 2025, filed 29 Oct 2025.